The Psychedelic Experience - A New Concept in Psychotherapy
Janet Sherwood, Myron J. Stolaroff, Willis W. Harman
Journal of Psychedelic Drugs April 1, 1968 DOI: 10.1080/02791072.1968.10524522 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Population | Patients |
| Interventions | Lysergic acid diethylamide Mescaline |
| Dose | massive doses |
| Topics | LSD Mescaline |
| Keywords | Psychotherapist Modalities Frame networking Treatment modality Administration probate law Hallucinogen Surgery Social science |
| Citations | 24 |
| Key findings | Simultaneous administration of massive doses of LSD and mescaline can produce a profound experience that may change a patient's evaluation of past life experiences and lead to new values and a more realistic frame of reference. |
Abstract
Abstract The authors, by the simultaneous administration of massive doses of lysergic acid diethylamide (LSD) and mescaline, tried to produce a unique experience for the patient which is to be so profound and impressive that it changes the patient's own evaluation of his past life experiences and consequently may lead him to establish new values and a more realistic frame of reference than had been established before. The experience, in a broad sense, is not unlike a religious conversion. The preparation of the patients for this experience, the mode of administration and dosage, and finally the modalities of experience under the drug are described. A few short illustrative cases are presented.
Comparable studies
Other case reports and case series on mescaline, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Parkinsonism after Taking Ecstasy 29-year-old man | 1999 | Case study | n = 1 |
| Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology A patient with methylenedioxyamphetamine intoxication | 1981 | Case study | n = 1 |
| A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane | 1955 | Case study | |
| Peyote and mescaline exposures: a 12-year review of a statewide poison center database Patients who used peyote or mescaline and required treatment | 2010 | Case series | |
| A Mescaline Associated Fatality A single deceased individual under the influence of mescaline | 1985 | Case study | n = 1 |
Citations in the library
Cited by 15
- The acute effects of classic psychedelics on memory in humans Psychopharmacology January 9, 2021
- Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy Frontiers in Psychology July 13, 2021
- Historic psychedelic drug trials and the treatment of anxiety disorders Depression and Anxiety July 5, 2020
- A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials. npj Mental Health Research July 2, 2024
- Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited? International Review of Psychiatry June 12, 2024
and 10 more in the library